Does CLONAZEPAM Cause Intensive care unit acquired weakness? 24 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Intensive care unit acquired weakness have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.1% of all adverse event reports for CLONAZEPAM.
24
Reports of Intensive care unit acquired weakness with CLONAZEPAM
0.1%
of all CLONAZEPAM reports
8
Deaths
23
Hospitalizations
How Dangerous Is Intensive care unit acquired weakness From CLONAZEPAM?
Of the 24 reports, 8 (33.3%) resulted in death, 23 (95.8%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Intensive care unit acquired weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does CLONAZEPAM Cause?
Drug ineffective (5,088)
Toxicity to various agents (4,028)
Completed suicide (3,320)
Drug abuse (3,287)
Off label use (2,590)
Anxiety (2,376)
Somnolence (2,260)
Dyspnoea (1,987)
Depression (1,838)
Insomnia (1,836)
What Other Drugs Cause Intensive care unit acquired weakness?
METHYLPREDNISOLONE (57)
PROPOFOL (55)
MIDAZOLAM (49)
PREDNISOLONE (47)
PREDNISONE (45)
MYCOPHENOLATE MOFETIL (42)
THIOPENTAL (41)
FENTANYL (40)
LEVETIRACETAM (40)
VANCOMYCIN (37)
Which CLONAZEPAM Alternatives Have Lower Intensive care unit acquired weakness Risk?
CLONAZEPAM vs CLONIDINE
CLONAZEPAM vs CLOPIDOGREL
CLONAZEPAM vs CLOPIDOGREL BESILATE
CLONAZEPAM vs CLOPIDOGREL BISULFATE
CLONAZEPAM vs CLORAZEPATE